EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company's ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, and immunotherapy diseases, as well as CNS diseases and gene therapy. It has a collaboration with GE Healthcare. The company was formerly known as Phoenix Solutions AS. EXACT Therapeutics AS was founded in 2012 and is based in Oslo, Norway.
Часто задаваемые вопросы
В каком секторе работает EXACT THERAP. AS NK 0004 (56F)?
EXACT THERAP. AS NK 0004 относится к сектору Здравоохранение.
Какова текущая цена акций EXACT THERAP. AS NK 0004 (56F)?
По последним данным, цена акций EXACT THERAP. AS NK 0004 составляет 0,01 €, предыдущее закрытие — 0,01 €.
Выплачивает ли EXACT THERAP. AS NK 0004 (56F) дивиденды?
Нет, EXACT THERAP. AS NK 0004 не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у EXACT THERAP. AS NK 0004 (56F)?
У компании EXACT THERAP. AS NK 0004 бета 0.069, что указывает на более низкую волатильность по сравнению с рынком в целом.
